fda warning letters compounding semaglutide news US sends 25 to telehealth companies over claims on compounded weight-loss drugs FDA warnings against compounded GLP-1s

Learn More Clinician-directed appetite suppressant therapy when appropriate

Children The safety and effectiveness of L CARNITIME PLUS TABLET 15 in children have not been established

"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital

Access this article Similar content being viewed by others References Shen J, Lall S, Zheng V, Buckley P, Damiano RJ Jr, Schuessler RB

Incubation of inhibitor 2 under the biochemical assay conditions with TGR and with or without NADPH resulted in no formation of derivatives of 2